IDEX Corporation reports developments for a global engineered products company organized around Health & Science Technologies, Fluid & Metering Technologies, and Fire & Safety / Diversified Products. Its updates cover quarterly operating results, organic sales trends, orders, margins, restructuring and productivity actions, dividends, share repurchases, and leadership changes.
Company news also reflects applied solutions across pumps, flow meters, valves, fluidic systems, medical diagnostic components, water systems, emergency rescue tools, satellite communications, and propulsion-related flow-control offerings through Mott Corporation.
IDEX (IEX) reported third-quarter 2026 sales of $951.7 million, up 8% year over year, and raised its full-year outlook. Diluted earnings per share rose to $1.95 from $1.70; adjusted diluted earnings per share increased to $2.33 from $2.03. Orders grew 13% to $991.2 million, with organic orders also up 13%.
Operating cash flow increased to $239.5 million from $203.5 million. All three segments posted higher sales and adjusted operating profitability. IDEX returned $129 million through dividends and share repurchases and extended its $800 million revolving credit facility to September 2031.
The company now projects 2026 organic sales growth of 6.5%–6.8%, versus 5%–6% previously, and adjusted diluted earnings per share of $8.91–$8.96, versus $8.70–$8.85. Higher employee-related costs and price/cost headwinds partly offset operational improvements.
IDEX (IEX) will release its third-quarter 2026 results before market open on October 28, 2026.
CEO Eric Ashleman and CFO Sean Gillen will host a conference call and webcast at 8:00 a.m. CT that day. A replay will be available on IDEX’s investor relations website.
IDEX Corporation (IEX) declared a regular quarterly cash dividend of $0.73 per common share, approved by its Board of Directors. The dividend is scheduled to be paid on October 16, 2026 to shareholders of record as of October 2, 2026. This marks IDEX’s 128th consecutive regular quarterly cash dividend payment.
IDEX (NYSE:IEX) reported second quarter 2026 net sales of $920.6 million, up 6% reported and 5% organically, with record orders of $1.07 billion, up 29%. Reported diluted EPS rose 11% to $1.93, while adjusted diluted EPS increased 12% to a record $2.32.
Gross margin improved 100 bps to 46.3% and adjusted EBITDA margin reached 28.1%. Operating cash flow was $200 million and free cash flow $177 million, both boosted by $21.1 million of IEEPA tariff refunds. The company returned $77 million via share repurchases and $54 million in dividends.
Health & Science Technologies led growth with 14% higher sales and a 270 bps adjusted EBITDA margin increase. IDEX raised 2026 organic sales guidance to 5%–6% and adjusted EPS guidance to $8.70–$8.85, and guided Q3 organic sales growth of 5%–7% with adjusted EPS of $2.20–$2.25.
Moog (NYSE: MOG.A, MOG.B) elected Carl R. Christenson as a Class A director, effective July 1, 2026, after expanding its Board from nine to ten members.
Christenson adds extensive public-company board, CEO, operations, and M&A experience in industrial, aerospace, defense and mission-critical applications.
IDEX (NYSE:IEX) will release its second quarter 2026 earnings on Wednesday, July 29, 2026, before market open. Management will host an investor conference call and webcast at 8:00 a.m. CT the same day.
The listen-only webcast, presentation, live call access details, and replay will be available on the company’s Investor Relations website.
IDEX (NYSE:IEX) declared a regular quarterly cash dividend of $0.73 per common share. The dividend is payable on July 24, 2026 to shareholders of record on July 6, 2026. This marks IDEX’s 127th consecutive regular quarterly cash dividend.
IDEX Corporation (NYSE:IEX) announced a regular quarterly cash dividend of $0.73 per common share. The dividend will be paid June 5, 2026 to shareholders of record as of May 22, 2026. This is the company’s 126th consecutive regular quarterly cash dividend payment.
IDEX (NYSE: IEX) reported Q1 2026 results: sales $886.9M (+9% reported, +5% organic), orders $988.3M (record, +13% reported, +10% organic), GAAP diluted EPS $1.61 (+28%) and adjusted diluted EPS $2.00 (+14%).
The company returned capital via $76M share repurchases and $53M dividends, raised full‑year organic sales guidance to 3%–4% and adjusted EPS guidance to $8.35–$8.55.
Mott (IEX) and deltaVision announced a formal partnership on April 17, 2026 to offer deltaVision valves and Mott propulsion‑grade filtration and flow assemblies to North American spacecraft manufacturers. The collaboration aims to shorten lead times, provide contamination‑controlled integrated propulsion feed‑system assemblies, harmonize qualification/testing across U.S., EU and international missions, and pursue joint development of next‑generation chemical and electric propulsion flow‑control technologies.